Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » Therapeutic Areas

Do you live in constant pain? Find clinical trials for pain.

Search Our Drug Database FREE For 5 days!

Access detailed profiles on more than 4,000 new drug therapies in active clinical trials worldwide.

Request a demo


View By:YearCompanyConditionsTherapeutic AreasDrug Names

FDA Approved Drugs by Therapeutic Area

Search by therapeutic area for drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Click on an area below to view the complete list of drugs in that category or review descriptions for our therapeutic area list to assist you in your search.

Find out more about the types of drugs included in this listing.

FDA Approved Drugs for Psychiatry/Psychology

Drugs Approved in 2013

Brintellix (vortioxetine); Takeda Pharmaceuticals USA; For the treatment of Major Depressive Disorder, Approved October 2013

Fetzima (levomilnacipran); Forest Laboratories; For the treatment of major depressive disorder, Approved July 2013

Zubsolv (buprenorphine and naloxone); Orexo AB; For the maintenance treatment of opioid dependence, Approved July 2013

Drugs Approved in 2012

Qsymia (phentermine + topiramate extended-release); Vivus; For the treatment of chronic weight management, Approved July 2012

Quillivant XR (methylphenidate hydrochloride); NextWave Pharmaceuticals; For the treatment of Attention Deficit Hyperactivity Disorder, Approved September 2012

Drugs Approved in 2011

Intermezzo (zolpidem tartrate sublingual tablet); Transcept Pharmaceuticals; For the treatment of insomnia, Approved November 2011

Viibryd (vilazodone hydrochloride); Clinical Data; For the treatment of major depressive disorder, Approved January 2011

Drugs Approved in 2010

Latuda (lurasidone); Sunovion; For the treatment of schizophrenia, Approved October 2010

Oleptro (trazodone hydrochloride); Labopharm; For the treatment of major depressive disorder, Approved February 2010

Vivitrol (naltrexone for extended-release injectable suspension); Alkermes; For the prevention of relapse to opioid dependence, Approved October 2010

Drugs Approved in 2009

Edluar (zolpidem tartrate); Orexo; For the treatment of insomnia, Approved March 2009

Fanapt (iloperidone); Vanda; For the treatment of schizophrenia, Approved May of 2009

Intuniv (guanfacine extended-release); Shire Pharmaceuticals; For the treatment of ADHD in children and adolescents, Approved September 2009

Saphris (asenapine); Schering-Plough; For the treatment of schizophrenia and manic or mixed bipolar 1 episodes, Approved August of 2009

Drugs Approved in 2008

Aplenzin (bupropion hydrobromide); Biovail Laboratories; For the treatment of major depressive disorder, Approved April 2008

Stavzor (valproic acid delayed release); Banner Pharmacaps; For the treatment of bipolar manic disorder, seizures and migraine headaches, Approved July 2008

Drugs Approved in 2007

Vyvanse (Lisdexamfetamine Dimesylate); New River; For the treatment of Attention-Deficit/Hyperactivity Disorder, Approved February 2007

Drugs Approved in 2006

Chantix (varenicline); Pfizer; For the treatment of nicotine addiction, Approved May 2006

Invega (paliperidone); Janssen Pharmaceuticals; For the treatment of schizophrenia, Approved December 2006

Vivitrol (naltrexone for extended-release injectable suspension); Alkermes; For the treatment of alcohol dependence, Approved April 2006

Drugs Approved in 2004

Cymbalta (duloxetine); Eli Lilly; For the treatment of major depressive disorder, Approved August 2004

Drugs Approved in 2002

Abilify (aripiprazole); Bristol-Myers Squibb, Otsuka America Pharmaceutical; Oral drug for the treatment of schizophrenia, Approved November 2002

Geodon (ziprasidone mesylate); Pfizer; To control agitated behavior and psychotic symptoms in schizophrenia patients, Approved June 2002

Lexapro (escitalopram oxalate); Forest Laboratories; An orally administered selective serotonin reuptake inhibitor useful for the treatment for major depressive disorder, Approved August 2002

Paxil CR (paroxetine hydrochloride); GlaxoSmithKline; Oral tablet for the treatment of depression and panic disorder, Approved February 2002

Ritalin LA (methylphenidate HCl); Novartis; Oral capsules for the treatment Attention-Deficit/Hyperactivity Disorder (ADHD), Approved June 2002

Strattera (atomoxetine HCl); Eli Lilly; For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents and adults., December 2002

Subutex/Suboxone (buprenorphine/naloxone); Reckitt Benckiser; Oral tablets for the treatment of opiate dependence, Approved October 2002

Zoloft (sertraline HCl); Pfizer; Oral tablets for the treatment of premenstrual dysphoric mood disorder (PMDD), Approved May 2002

Drugs Approved in 2001

Adderall XR; Shire Pharmaceuticals; Once-daily medication for the treatment of attention deficit/hyperactivity disorder (ADHD), Approved October 2001

Focalin (dexmethylphenidate HCl); Celgene; For the treatment of attention deficit hyperactivity disorder (ADHD), Approved November 2001

Metadate CD; Celltech Pharmaceuticals; Oral capsules for the treatment of attention deficit hyperactivity disorder, Approved April 2001

Prozac Weekly (fluoxetine HCl); Eli Lilly; For the treatment of depression, Approved February 2001

Remeron SolTab (mirtazapine); Organon; Orally disintegrating tablet for the treatment of depression, Approved January 2001

Ziprasidone (ziprasidone hydrochloride); Pfizer; Oral capsule for the treatment of schizophrenia, Approved February 2001

Drugs Approved in 2000

Concerta; Alza; For the treatment of Attention Deficit Hyperactivity Disorder, Approved August 2000

Drugs Approved in 1999

Effexor (venlafaxin HCL); Wyeth; Treatment for generalized anxiety disorder, Approved March 1999

Paxil CR (paroxetine hydrochloride); SmithKline Beecham; Treatment for depression, Approved March 1999

Sonata; American Home Products; Treatment fo insomnia, Approved August 1999

Drugs Approved in 1998

Celexa; Forest Laboratories; Treatment for depression, Approved July 1998

Clomipramine hydrochloride; Mylan Laboratories; Generic equivalent of Anafranil, Approved April 1998

Cylert; Abbott Laboratories; Treatment for Attention Deficit Disorder, Approved October 1998

Marplan Tablets; Roche; Treatment of Depression, Approved August 1998

Naltrexone Hydrochloride Tablets; Barr Laboratories; Generic equivalent of Revia, Approved May 1998

Prochlorperazine; IVAX; Generic equivalent of SmithKline Beecham's Compazine, Approved January 1998

Drugs Approved in 1997

Effexor XR (venlafaxin HCI); Wyeth; Treatment of depression, Approved October 1997

Generic Transdermal Nicotine Patch; Sano; Generic equivalent of Habitrol, Approved October 1997

LUVOX (fluvoxamine maleate); Solvay Pharmaceuticals, Pharmacia & Upjohn; Treatment for obsessive compulsive disorder (OCD) in children and adolescents, Approved April 1997

Seroquel (R) (quetiapine fumarate) Tablets; AstraZeneca; Treatment for schizophrenia, Approved September 1997

Trazadone 150mg; Teva Pharmaceutical; Generic equivalent of Desyrel 7, Approved May 1997

Zoloft (sertraline HCl); Pfizer; Treatment for panic disorder, Approved July 1997

Zoloft (sertraline HCl); Pfizer; Treatment of panic disorder in children ages 6-17, Approved October 1997

Zyban Sustained-Release Tablets; GlaxoSmithKline; Treatment for smoking cessation, Approved May 1997

Drugs Approved in 1996

Adderall (mixed salts of a single-entity amphetamine); Richwood Pharmaceutical; Treatment for attention-deficit/hyperactivity disorder, Supplemental NDA Approved February 1996

ARICEPT (donepezil hydrochloride); Eisai; Treatment for Alzheimer's Disease, Approved December 1996

Depakote (divalproex sodium); Abbott Laboratories; Treatment for migraine headaches, Approved March 1996

Lithobid (Lithium Carbonate); Solvay Pharmaceuticals; Treatment for manic depression, Approved January 1996

NicoDerm CQ; SmithKline Beecham, Hoechst Marion Roussel, Alza; Treatment for smoking cessation, Approved August 1996

Nicorette (nicotine polacrilex); SmithKline Beecham; Over-the-counter aid in smoking cessation, Approved February 1996

Nicotrol nasal spray; Pharmacia & Upjohn; Treatment for nicotine addiction, Approved March 1996

Nicotrol transdermal patch; McNeil Consumer Products; Treatment for smoking cessation, Approved July 1996

Paxil (paroxetine hydrochloride); SmithKline Beecham; Treatment for panic disorder, Approved May 1996

Redux (dexfenfluramine hydrochloride); Wyeth; Treatment for obesity, Approved May 1996

Remeron (Mirtazapine); Organon; Treatment for depression, Approved June 1996

Risperdal Oral Formulation; Janssen Pharmaceuticals; Treatment for schizophrenia, Approved July 1996

Zyprexa; Eli Lilly; Treatment of the symptoms of psychotic disorders, Approved September 1996